SEC Continues its Crusade Against Foreign Bribery
By Gordon Schnell The reinvigorated efforts of the Securities and Exchange Commission (SEC) to fight foreign bribery continue to pay off. This week, the SEC announced that the drug giant, Pfizer, has agreed to pay $60 million to settle criminal and civil charges that its subsidiaries bribed foreign officials in Europe and Asia in order to win business there. Under the Foreign Corrupt Practices Act (FCPA), it is illegal for...